June 2021
4:49 PM IST
News Headlines
Sharad Pawar, Yashwant Sinha call meet to put up united opposition        Kerala to implement tourism projects in time-bound manner: Riyas        BCCI to donate Rs 10 cr for preparations of Olympic-bound athletes        WTC Final, Day 3: NZ bowl out India for 217 in 1st innings, Jamieson picks 5 wickets        AIBEA to hold National Webinars from Jul 1 to commemorate 52nd anniversary of Bank Nationalisation        France elects regional leaders, preps for presidential vote        Argentina reports first confirmed case of ‘Black Fungus’: Reports        Bengal plans more COVID beds for women amid third wave threat        Delhi eases COVID restrictions        COVID-19: India records less than 60,000 cases after 81 days        WTC Final, Day 2: India 146/3 at stumps against NZ        Union Bank of India inks MOU with NSIC to support MSMEs with credit requirements        Seven dead, 13 injured after plane crash-lands in Russia's Kemerovo region        Ebrahim Raisi elected Iran's new president        MHA asks states, UTs to not lower guard, calibrated opening up of lockdown advised        PM congratulates LS Speaker Om Birla for completing 2 years in office        Centre invites 14 J&K leaders to attend all-party meeting on June 24        Tour de France to hold women''s cycling race in July 2022        Will always regret missing hundred on Test debut but will get one next time: Shafali Verma        Nadal, Osaka both out for Wimbledon; she'll go to Olympics        
Home   | Main News   | Kerala  | National   | International  | Business   | Sports   | Entertainment   | Columns   | Offbeat   | About Deepika 
International News
WHO China chief says approval for 1st Chinese vaccine a ''milestone achievement''
Beijing: The WHO''s China chief has termed the conditional approval granted by the global health body to China’s first COVID-19 vaccine Sinopharm as a “milestone achievement” which will create an opening to significantly increase the global supply of vaccines.

“The decision announced on Friday by the World Health Organisation in Geneva to grant Emergency Use Listing (EUL) to a COVID-19 vaccine manufactured in China represents a milestone achievement," Dr Gauden Galea, WHO Representative to China, said in a statement here on Saturday.

He said the approval of Sinopharm vaccine may spur similar recognition by the WHO to 15 other coronavirus vaccines being developed by China.

“One vaccine has received EUL, but we know that there are over fifteen additional COVID-19 vaccines in advanced development in China. Today’s milestone achievement should spur other manufacturers to pursue this route and add to the global vaccine arsenal," he said.

“It should also encourage an even greater contribution from China to global supply and vaccine equity," he said. In addition to Sinopharm, WHO is expected to grant approval to another Chinese vaccine, Sinovac, in the coming days.

In a big relief for China, the WHO on Friday finally granted the conditional approval to its Sinopharm COVID-19 vaccine for emergency use making it the first vaccine from a non-western country to get the recognition.

The WHO listing is expected to help China step up its vaccine diplomacy amid the surge in coronavirus vaccines in several countries.

China is also expected to ramp up its vaccine supplies especially in South Asia as the supplies from India faced difficulties in view of the COVID-19 surge in the country.

China has approved about five of its vaccines for emergency use and especially using Sinopharm and Sinovac vaccines for both at home and abroad.

While WHO has listed the Pfizer/BioNTech, Astrazeneca-SK Bio, Serum Institute of India, Moderna and Janssen vaccines for emergency use, the Chinese vaccine got delayed recognition due to data related issues.

Commenting on Sinopharm’s WHO approval, Yang Xiaoming, chairman of Sinopharm China National Biotec Group (CNBG), which rolled out the vaccine, said until now his firm has produced 200 million doses mostly to be sent to foreign countries.

"The vaccines have been approved for registration, marketing and emergency use in more than 60 countries and regions, and have helped 80 countries. More than 100 countries plan to use it," he told state-run CGTN-TV.

Though China has been supplying vaccines to various countries, especially in Asia and Africa, many countries hesitated using the vaccine as it has not secured recognition from the WHO.

China was eagerly awaiting the global health body''s nod for it to aggressively push the vaccine among different countries.

China has joined the COVAX global vaccine distribution campaign backed by GAVI and WHO and committed to provide 10 million vaccines. The WHO approval to Sinpharm is expected to speed up China’s supplies to COVAX.

COVAX aims to send vaccines for free to 92 lower-income countries and to help another 99 countries and territories procure them.

The two jab Sinopharm vaccine is an inactivated vaccine called SARS-CoV-2 Vaccine (Vero Cell). Its easy storage requirements make it highly suitable for low-resource settings, the WHO press release said.

Its efficacy which stated to be 79 per cent is, however, below the efficacy rates of other WHO vaccines which are in the range of 90 per cent.

WHO has okayed Sinopharm usage from 18 years and above, clarifying lingering doubts about its usage for people above 59 years.

"WHO is not recommending an upper age limit for the vaccine because preliminary data and supportive immunogenicity data suggest the vaccine is likely to have a protective effect in older persons," the WHO said.

France elects regional leaders, preps for presidential vote
Argentina reports first confirmed case of ‘Black Fungus’: Reports
Seven dead, 13 injured after plane crash-lands in Russia's Kemerovo region
Ebrahim Raisi elected Iran's new president
UN: Millions driven from homes in 2020 despite COVID crisis
Hong Kong newspaper increases print run after arrests
Back home: Biden has daunting to-do list after European tour
China successfully launches first crew to new space station
Biden, Putin discuss ambassadors, nuclear weapons and more
UK expands COVID-19 vaccination drive to cover all over-21s
China says nuclear fuel rods damaged, no radiation leak
Biden sells G-7 on global tax, but U.S. Congress is a hurdle
US Senate confirms first Muslim-American as federal judge
G-7 nations gather to pledge 1B vaccine doses for world
Indian-Americans regularly encounter discrimination: Survey
French leader Macron slapped in face on visit to small town
Up to 50 killed as express train smashes intro derailed coaches of passenger train in Pakistan''s Sindh
New Constitutional Bench formed to hear petitions against House dissolution in Nepal
Data recorder recovered from fire-stricken ship sinking off Sri Lanka
Biden widens list of Chinese firms off-limits for investment
George Clooney says Capitol attack put Trump family 'into the dustbin of history'
 Los Angeles: Hollywood star George Clooney has condemned the attack on the Capitol Hill in the US by  
'Mean Girls' won't be returning to Broadway
Ian McKellan is 'happy' Elliot Page came out as transgender
A R Rahman thanks fans for support during 'difficult times'
Kerala to implement tourism projects in time-bound manner: Riyas
 Thiruvananthapuram: Kerala will complete its tourism projects in a time-bound manner by giving top p
Kerala govt orders SIT probe into ''illegal'' tree felling in Wayanad
LDF govt hand in glove with timber mafias, alleges Union Minister Muraleedharan
COVID-19:Kerala reports 14,233 new cases, 173 deaths
Bengal plans more COVID beds for women amid third wave threat
 Kolkata: The West Bengal government is planning to allot more hospital beds for women as it prepares
Delhi eases COVID restrictions
MHA asks states, UTs to not lower guard, calibrated opening up of lockdown advised
PM congratulates LS Speaker Om Birla for completing 2 years in office
Untitled Page
Rashtra Deepika LTD
Copyright @ 2021 , Rashtra Deepika Ltd.